Alexandria Co. For Pharmaceuticals & Chemical Industries Share Price
Stocks
AXPH
EGS38341C011
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,268.53 EGP | +0.71% |
|
+4.87% | +58.49% |
| Market Cap | 5.6B 112M 97.2M 90.77M 83.27M 157M 10.69B 159M 1.06B 418M 5.36B 422M 413M 17.72B | P/E 2024 |
4.86x | P/E 2025 | 5.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.31B 107M 92.31M 86.2M 79.08M 149M 10.16B 151M 1.01B 397M 5.09B 401M 392M 16.83B | EV / Sales 2024 |
0.51x | EV / Sales 2025 | 0.71x |
| Free-Float |
17.74% | Yield 2024 |
14.2% | Yield 2025 | 14.1% |
| 1 day | +0.71% | ||
| 1 week | +4.87% | ||
| Current month | +4.87% | ||
| 1 month | +7.30% | ||
| 3 months | +29.50% | ||
| 6 months | +58.52% | ||
| Current year | +58.49% |
| 1 week | 1,220 |  | 1,439 |
| 1 month | 1,121.56 | | 1,439 |
| Current year | 701.66 | | 1,439 |
| 1 year | 640 | | 1,439 |
| 3 years | 120 | | 1,439 |
| 5 years | 85 | | 1,439 |
| 10 years | 46 | | 1,439 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Ahmed Fuad
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | +4.87% | +98.45% | +735.99% | 128M | |
| -0.79% | +3.04% | +84.71% | +160.69% | 1,062B | |
| +0.27% | +0.80% | +50.64% | +49.27% | 619B | |
| +0.64% | -2.18% | +23.44% | +63.29% | 431B | |
| +0.71% | +3.93% | +47.75% | +38.58% | 358B | |
| +0.64% | -0.63% | +36.39% | +41.44% | 293B | |
| +0.39% | -6.48% | +7.62% | +9.04% | 247B | |
| +1.72% | +6.69% | +44.33% | +62.45% | 219B | |
| +3.92% | -7.80% | +5.39% | -42.52% | 200B | |
| +1.45% | +2.43% | +20.95% | +65.34% | 162B | |
| Average | +1.10% | -1.54% | +41.97% | +118.36% | 359.24B | |
| Weighted average by Cap. | +0.60% | -0.83% | +48.80% | +75.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.77B 35.51M 30.71M 28.68M 26.31M 49.49M 3.38B 50.28M 337M 132M 1.69B 133M 130M 5.6B | 2.75B 55.24M 47.78M 44.62M 40.93M 76.99M 5.26B 78.21M 524M 205M 2.63B 207M 203M 8.71B |
| Net income | 217M 4.35M 3.76M 3.52M 3.22M 6.06M 414M 6.16M 41.24M 16.19M 208M 16.34M 15.98M 686M | 391M 7.86M 6.8M 6.35M 5.82M 10.95M 748M 11.12M 74.45M 29.22M 375M 29.5M 28.85M 1.24B |
| Net Debt | -149M -3M -2.59M -2.42M -2.22M -4.18M -285M -4.24M -28.4M -11.15M -143M -11.25M -11.01M -473M | -282M -5.66M -4.89M -4.57M -4.19M -7.89M -538M -8.01M -53.62M -21.05M -270M -21.25M -20.78M -892M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | EGP 1,268.53 | +0.71% | 3,556 |
| 05/08/26 | EGP 1,259.56 | -0.36% | 1,513 |
| 04/08/26 | EGP 1,264.12 | -4.79% | 5,295 |
| 03/08/26 | EGP 1,327.71 | +6.48% | 13,978 |
| 02/08/26 | EGP 1,246.92 | +3.08% | 5,875 |
- Stock Market
- Stocks
- AXPH Stock
Select your edition
All financial news and data tailored to specific country editions
